Global Hospital Discharges for Dorsalgia Cases by Country

The analysis of Global Hospital Discharges for Dorsalgia Cases indicates notable disparities among countries. In 2023, Germany exhibited the highest number of discharges (296.34 thousand), with a slight year-on-year growth of 0.69%. Switzerland saw a decline of 1.07%, while Chile experienced a 0.67% increase. Israel's discharges slightly decreased by 0.17%, and New Zealand witnessed the most significant rise at 2.23%. Over the past five years, these nations have displayed varying trends, with Germany and New Zealand showing growth and Switzerland and Israel experiencing declines.

Future trends to watch involve technological advancements in dorsalgia treatment, changes in healthcare policies, and demographic shifts impacting demand for hospital services. Additionally, evolving medical practices and public health initiatives aimed at preventing dorsalgia may influence discharge rates across different regions. Economic factors and healthcare infrastructure improvements will also play pivotal roles in shaping these trends globally.

Top countries in Hospital Discharges for Dorsalgia Cases by Country

# 5 Countries Units (Hospital Discharges) Last Year YoY 5-years CAGR
1 1 Germany 296,340 2023 +7.16% +0.69% View data
2 2 Switzerland 7,520 2023 +1.63% -1.07% View data
3 3 Chile 5,480 2023 +7.83% +0.67% View data
4 4 Israel 3,430 2023 +4.25% -0.17% View data
5 5 New Zealand 3,220 2023 +2% +2.23% View data

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease